Neurocrine Bio. (NBIX) Conference Presentation Implies Ingrezza has Just Scratched the Surface - Cowen
Tweet Send to a Friend
Cowen analyst Phil Nadeau reiterated an Outperform rating and $115.00 price target on Neurocrine Bio. (NASDAQ: NBIX) after hosting a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
